R&D Changing Faces – Pharma and Biotech July 2024 We’re back on track this month with Changing Faces as we look back at the month in pharma and biotech hires and – especially this month – departures.
R&D Changing Faces – Pharma and biotech May and June 2024 Welcome back to another edition of Changing Faces.
R&D Changing Faces: Pharma and biotech hires from April 2024 Coming to you well over a month late, we still want to acknowledge the many comings and goings we saw in the biotech industry in April.
R&D Changing Faces: Pharma and biotech hires from March 2024 Once again in March, the pharmaceutical world saw a series of notable hires. From biotech to pharma, companies are strengthening their teams with experienced professionals.
R&D Changing Faces: Pharma and biotech hires from February 2024 February may be the shortest month, but we got an extra day this year and that left plenty of time for personnel announcements in the pharma world.
R&D Changing Faces: Pharma and biotech hires from January 2024 It’s a new year, so we’re kicking it off with the relaunch of Changing Faces after we lost the thread a bit last year.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.